PARENTERAL FORMULATIONS OF 1-(5-TERT-BUTYL-2-P-TOLYL-2H-PRY RAZOL3-YL)-3-(4-(2-MORPHOLIN-4-YL-ETH OXY)-NAPHTHALEN-1-YL)-UREA AND A CYCLODEXTRIN

Details for Australian Patent Application No. 2002319782 (hide)

Owner BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.

Inventors CAPPOLA, Michael L.; WAY, Susan, L.

Pub. Number AU-A-2002319782

PCT Number PCT/US02/25110

PCT Pub. Number WO2003/015828

Priority 60/313,527 20.08.01 US

Filing date 8 August 2002

Wipo publication date 3 March 2003

International Classifications

A61K 047/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 037/00 Drugs for immunological or allergic disorders

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/313,527 20.08.01 US

29 May 2003 Application Open to Public Inspection

  Published as AU-A-2002319782

6 May 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002319783-METHODS FOR THE IDENTIFICATION OF INHIBITORS OF FERREDOXIN NADP OXIDOREDUCTASE EXPRESSION OR ACTIVITY IN PLANTS

2002319781-FLEXIBLE LOYALTY POINTS PROGRAMS